IRCT20210223050469N4已完成2 期
Evaluation of the effect of using collagen foam biomaterial for bone formation in the treatment of open lifting sinus in CBCT images
Vice Chancellor for Research, Islamic Azad University, Tehran Dental Branch0 个研究点目标入组 12 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 25 years 至 65 years(—)
- 性别
- All
入选标准
- •Confirmation of maxillary sinus expansion through panoramic radiography and the need for sinus lifting treatment
- •Patients in the age range of 25 to 65 years
排除标准
- •Presence of systemic /infectious disease
- •Alcohol consumption
- •Uncontrolled or poorly controlled diabetes
- •Taking immunosuppressive drugs
- •Taking bisphosphonate drugs
- •History of head and neck radiotherapy
- •Active maxillary sinus disease
- •Chronic steroid treatment
研究者
相似试验
尚未招募
不适用
Healing of chronic diabetic foot ulcers.CTRI/2022/02/039944AIIMS Bhubaneswar
已完成
3 期
Comparative Evaluation of Collagen Sponge with recombinant bone morphogenic protein 2 for Alveolar Ridge Preservation: A Pilot Clinical StudyEnrolled the healthy patient who need to extract the single-tooth extraction in the premolar tooth due to unrestorable (caries, fracture, or orthodontic treatment) with an intact buccal bone plate (more than 50%)Alveolar ridge preservation, rhBMP-2, Collagen.TCTR20240715009Thailand Science Research and Innovation (TSRI), and National Science, Research and Innovation Fund (NSRF)14
招募中
3 期
Investigating the effect of Gelfoam on reducing swelling, bleeding and pain after mandibular wisdom tooth surgery.IRCT20221226056929N1Bandare-abbas University of Medical Sciences58
已完成
不适用
Verification of the efficacy of collagen peptide for the purpose of flail-Locomotive Syndrome PreventioJPRN-UMIN000023388itta Gelatin Inc. Peptide Division.76
招募中
不适用
Scaffold Implant for Rotator Cuff Lesions Encountered on the Supraspinatus TendoSupraspinatus tendon tearsMusculoskeletal - Other muscular and skeletal disordersACTRN12611001082998Rotation Medical, Inc.36
